Amazon Introduces Wegovy Pill in Pharmacy: Implications for Hims & Hers, WW International, and GoodRx Holdings

Key Points

• Novo Nordisk has launched its Wegovy GLP-1 drug in pill form, becoming the first company to offer this option in 2026.

• Amazon is set to sell Wegovy pills for as low as $25 per month with insurance, leveraging its vast customer base of 200 million Prime members.

• The price range for Wegovy from competitors like Hims & Hers, WW International, and GoodRx will be comparable as they aim to compete with Amazon’s offering.

In a significant move within the GLP-1 drug market, Novo Nordisk has introduced its Wegovy medication in pill format, enhancing consumer accessibility. Previously available only as injections, Wegovy now offers a simpler alternative, potentially increasing market demand for weight loss solutions. Amazon has entered the fray by offering the Wegovy pill through its platform, with prices starting at $25 with insurance, ready to compete against other retailers.

This shift marks a competitive landscape featuring major players like Eli Lilly, whose injectable products previously dominated the space. With Amazon’s extensive reach, the retail giant is poised to capture a significant share of the growing market for GLP-1 medications, putting pressure on traditional sellers as more consumers may be inclined to adopt weight loss drugs in pill form.